James R. Kasinger sold $626K of CRSP stock

James R. Kasinger, General Counsel and Secretary of CRISPR Therapeutics AG (CRSP), sold 10,400 shares of CRSP stock worth $626K, per an SEC Form 4 filed Sep 24, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 22, 2026, 2 days before it was made public.

CRSP has moved -17.7% since the trade date, from $59.03 to $48.56 (Nov 5, 2026 close).